Original BioMedicals Co., Ltd.
6483
Rank in Stocks
#24774
Original BioMedicals Co., Ltd. is a biotechnology company focused on creating... Original BioMedicals Co., Ltd. is a biotechnology company focused on creating novel chemical compounds to fulfill critical medical requirements, with an initial emphasis on the healthcare landscape in Taiwan. Its current product pipeline encompasses several key developments: Radprotect (A01): A pre-clinical stage compound designed to offer protection against radiation exposure. CCM-Ami (A02): Engineered to shield healthy tissues from the damaging side effects of both chemotherapy drugs and ionizing radiation. GLP-1 CCM (P01): A therapeutic agent developed for the management of type 2 diabetes. The firm was established in 2011 and operates from its base in Taipei, Taiwan.
Share Price
$0.4587911
Last synced: 2026-11-10
Market Cap
$30.65M
Change (1 day)
2.03%
Change (1 year)
37.39%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Original BioMedicals Co., Ltd. (6483)
Category
Healthcare
EPS for Original BioMedicals Co., Ltd. (6483)
EPS as of June 2026 TTM: $-0.05
According to Original BioMedicals Co., Ltd.'s latest financial reports, its current EPS (TTM) is $-0.05. At the end of 2025 the company had an EPS of $-0.05, a decrease compared to its 2024 EPS of $-0.03.
EPS history for Original BioMedicals Co., Ltd. from 2013 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.05 | -5.00% |
| 2025 | $-0.05 | 41.50% |
| 2024 | $-0.03 | -11.93% |
| 2023 | $-0.04 | 40.71% |
| 2022 | $-0.03 | -4.11% |
| 2021 | $-0.03 | -34.82% |
| 2020 | $-0.04 | -14.67% |
| 2019 | $-0.05 | -45.20% |
| 2018 | $-0.10 | -34.96% |
| 2017 | $-0.15 | 14.01% |
| 2016 | $-0.13 | -9.33% |
| 2015 | $-0.14 | -9.47% |
| 2014 | $-0.16 | -42.11% |
| 2013 | $-0.27 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.50 | -13,787.16% |
DE
|
|
| $6.08 | -12,894.95% |
DE
|
|
| $1.55 | -3,364.42% |
JP
|
|
| $3.66 | -7,805.26% |
CH
|
|
| $0.45 | -1,047.37% |
IL
|
Questions about Original BioMedicals Co., Ltd.'s earnings per share (EPS)
What is Original BioMedicals Co., Ltd.'s earnings per share (EPS)?
Original BioMedicals Co., Ltd.'s earnings per share (EPS) over the last twelve months is $-0.05, as of Jun 2026.
What was Original BioMedicals Co., Ltd.'s earnings per share (EPS) in 2025?
In 2025, Original BioMedicals Co., Ltd.'s earnings per share (EPS) was $-0.05, compared with $-0.03 in 2024.
How has Original BioMedicals Co., Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Original BioMedicals Co., Ltd.'s earnings per share (EPS) was highest in 2024 ($-0.03) and lowest in 2025 ($-0.05).
How does Original BioMedicals Co., Ltd.'s earnings per share (EPS) compare with similar companies?
Original BioMedicals Co., Ltd.'s earnings per share (EPS) ($-0.05) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.50.